Ning Ding
Impact in
- Hepatology top 5%
- Liver physiology and pathology
-
- Vitamin D Research Studies
Papers in
-
- RNA modifications and cancer 4
- Epigenetics and DNA Methylation 4
- Protein Degradation and Inhibitors 3
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 4
- Co-authors
- Michael Downes (8 shared papers)Ronald M. Evans (8 shared papers)Christopher Liddle (6 shared papers)Mara H. Sherman (5 shared papers)Ruth T. Yu (4 shared papers)Mathias Leblanc (3 shared papers)Annette R. Atkins (4 shared papers)Ming‐Xiao He (2 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (3 papers)Cell (2 papers)Pharmaceutical Research (2 papers)Frontiers in Oncology (2 papers)Journal of Nanobiotechnology (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Ning Ding
54 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Hepatology 170
- Pathology and Forensic Medicine 336
- Molecular Biology 925
- Oncology 340
- Cancer Research 170
Countries citing papers authored by Ning Ding
This map shows the geographic impact of Ning Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Ding more than expected).
Fields of papers citing papers by Ning Ding
This network shows the impact of papers produced by Ning Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Ding. The network helps show where Ning Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Ning Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Vitamin D Receptor/SMAD Genomic Circuit Gates Hepatic Fibrotic Response Hit paper breakdown → | 2013 | 490 |
| 2 | 2008 | 186 | |
| 3 | 2015 | 171 | |
| 4 | 2018 | 154 | |
| 5 | 2017 | 104 | |
| 6 | Oxidative Stress, Inflammation, Gut Dysbiosis: What Can Polyphenols Do in Inflammatory Bowel Disease? Hit paper breakdown → | 2023 | 81 |
| 7 | 2022 | 78 | |
| 8 | 2015 | 74 | |
| 9 | 2008 | 63 | |
| 10 | 2020 | 58 | |
| 11 | 2011 | 53 | |
| 12 | 2022 | 53 | |
| 13 | 2016 | 50 | |
| 14 | 2022 | 37 | |
| 15 | 2020 | 30 | |
| 16 | 2022 | 29 | |
| 17 | 2023 | 27 | |
| 18 | 2023 | 26 | |
| 19 | 2023 | 23 | |
| 20 | 2011 | 20 |
About Ning Ding
Ning Ding is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Immunology, Oncology and Biomedical Engineering, having authored 57 papers that have together received 2.0k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (6 papers), Nanoparticle-Based Drug Delivery (6 papers), RNA modifications and cancer (4 papers), Pancreatic function and diabetes (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Epigenetics and DNA Methylation (4 papers), Protein Degradation and Inhibitors (3 papers) and Diabetes and associated disorders (3 papers). The work is most often cited by research in Hepatology (170 citations), Pathology and Forensic Medicine (336 citations), Molecular Biology (925 citations), Oncology (340 citations) and Cancer Research (170 citations). Ning Ding has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Michael Downes, Ronald M. Evans, Christopher Liddle, Mara H. Sherman, Ruth T. Yu, Mathias Leblanc, Annette R. Atkins, Ming‐Xiao He, Sally Coulter and Thomas G. Boyer. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cell, Pharmaceutical Research, Frontiers in Oncology and Journal of Nanobiotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.